glp-1 drugs for insulin resistance GLP-1 Agonists - What is it?

Retatrutide is a triple agonist GLP 1, GIP, and glucagon. In TRIUMPH 1, 2,339 adults with obesity (no diabetes) were randomized to 4, 9, or 12 mg, or placebo, for 80 weeks. On treatment: GLP 1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP 1 Receptor Agonists: A Possible Solution for When Diet and Exercise Are Just Not Enough!: Thrive Wellness Center For Women: Gynecology GLP 1 receptor agonists How Wegovy, Ozempic, and Mounjaro work The Influence of Glucagon like Peptide 1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition When fatigue shows up on GLP 1 therapy, I don't assume one cause. This is the framework I use clinically to guide evaluation. Save this and discuss persistent symptoms with your healthcare